Utah Medical Products (NASDAQ:UTMD) Shares Pass Above 200 Day Moving Average - Time to Sell?

Key Points

• Utah Medical Products shares rose above their 200-day moving average, trading as high as $72.37 versus the $66.51 average, with the latest price at $72.10.
• Analyst sentiment remains neutral: Weiss Ratings upgraded the stock from “hold (c-)” to “hold (c),” while the overall consensus rating is “Hold.”
• The company reported quarterly earnings of $0.84 per share on $8.53 million in revenue and declared a $0.31 quarterly dividend, equivalent to a 1.7% annual yield.

Utah Medical Products, Inc. (NASDAQ:UTMD - Get Free Report)'s share price passed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $66.51 and traded as high as $72.37. Utah Medical Products shares last traded at $72.10, with a volume of 10,733 shares trading hands.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings raised Utah Medical Products from a "hold (c-)" rating to a "hold (c)" rating in a research report on Wednesday. One research analyst has rated the stock with a Hold rating, According to MarketBeat.com, the stock currently has a consensus rating of "Hold".

Utah Medical Products Stock Down 0.0%

The business's 50 day simple moving average is $69.46 and its 200 day simple moving average is $66.51. The stock has a market cap of $229.28 million, a price-to-earnings ratio of 21.98 and a beta of 0.35.

Utah Medical Products (NASDAQ:UTMD - Get Free Report) last released its quarterly earnings data on Thursday, July 23rd. The medical instruments supplier reported $0.84 earnings per share for the quarter. The company had revenue of $8.53 million for the quarter. Utah Medical Products had a net margin of 29.04% and a return on equity of 8.79%.

Utah Medical Products Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, October 5th. Investors of record on Thursday, September 17th will be issued a dividend of $0.31 per share. The ex-dividend date is Thursday, September 17th. This represents a $1.24 dividend on an annualized basis and a yield of 1.7%. Utah Medical Products's dividend payout ratio (DPR) is presently 37.80%.

Institutional Trading of Utah Medical Products

Several institutional investors and hedge funds have recently bought and sold shares of the business. Jane Street Group LLC acquired a new stake in shares of Utah Medical Products in the first quarter valued at approximately $317,000. Geode Capital Management LLC increased its holdings in shares of Utah Medical Products by 6.5% during the 2nd quarter. Geode Capital Management LLC now owns 114,816 shares of the medical instruments supplier's stock worth $6,537,000 after acquiring an additional 7,040 shares during the last quarter. Rhumbline Advisers increased its holdings in shares of Utah Medical Products by 10.6% during the 2nd quarter. Rhumbline Advisers now owns 5,716 shares of the medical instruments supplier's stock worth $325,000 after acquiring an additional 550 shares during the last quarter. Russell Investments Group Ltd. raised its stake in Utah Medical Products by 550.5% in the 2nd quarter. Russell Investments Group Ltd. now owns 2,758 shares of the medical instruments supplier's stock valued at $157,000 after acquiring an additional 2,334 shares during the period. Finally, Invesco Ltd. raised its stake in Utah Medical Products by 33.8% in the 2nd quarter. Invesco Ltd. now owns 4,955 shares of the medical instruments supplier's stock valued at $282,000 after acquiring an additional 1,253 shares during the period. Institutional investors own 69.60% of the company's stock.

Utah Medical Products Company Profile

Utah Medical Products, Inc NASDAQ: UTMD, headquartered in Midvale, Utah, is a designer, manufacturer and marketer of single‐use medical devices focusing principally on respiratory therapy and patient monitoring applications. Since its founding in the late 1970s, the company has built a reputation for innovation in airway management and non‐invasive monitoring products used in acute and long‐term care settings.

The company's core product portfolio includes tracheostomy tubes and related accessories, endotracheal tube holders, disposable catheters and sensors for measuring end‐tidal carbon dioxide (CO₂).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source